Terrence C. Mcnulty Email & Phone Number

Assist six small to medium-sized manufacturing companies in increasing top-line monthly sales and profit margins that desire top sales representation in Oklahoma, Arkansas, and South-Central Kansas. The companies and the types of products distributed include: 1.) In2Bones (via Dolphin Medical)- Sell compression stability screws, staples, interphalangeal implants, & disposable instruments in the Operating Room to Orthopedic Foot/Ankle Specialists and Doctors of Podiatric Medicine. 2.) FCI Ophthalmics- Sell surgical implants and stents to Cataract Surgeons, Vitreoretinal Surgeons, Oculoplastic Surgeons, and Pediatric Ophthalmologists in the OR.3.) Designs for Vision- Sell telescoping loupes & headlights to General Surgeons, Neurosurgeons, Cardio-Thoracic Surgeons, & Dentists.4.) Ophthalogix (a Division of Evologics Company)- Sell amnion membrane tissue for corneal disease and conjunctival malformities. 5.) J2 Medical Supply- Sell PPE for healthcare institutions, B2B, Senior Assisted Living Centers, & government agencies.6.) Diopsys- Sell diagnostic capital equipment that objectively measures visual function from the cornea to the cerebral cortex. "An EKG of the visual system". Key Accomplishments:• Started Company from scratch, and utilized previous experience in running small companies, my contacts, and Social-Media to obtain solid contracts, with great products, that span a wide variety of different surgeons and Health Care Professionals.• Successful in the day-to-day operations, planning, and budgeting of the Company. And, the business acumen to be able to cross-sell all 6 lines to multiple surgeons with different specialties. • By developing and implementing a very strategic business plan, and practicing consultative selling solutions, increased top-line sales in 4 out of the 6 companies vs same time previous year.• Company sales to hit $1M by end of 4th QTR, 2021

Distribution channel for Orthopedic and Ophthalmic Surgical Implants and Instrumentation, Capital Equipment (including diagnostic), Medical Supplies (full line of PPE, as well as, amniotic membrane), and clinical services.

Dublin, Coolock, Ie

Having launched approximately 23 disruptive, best-in-class technologies in prior sales positions provided the business acumen to launch, sell and retain surgeons' use of a new implant & new surgical procedure known as Xen 45 Micro Gel Stent. Managed all sales, intra-territory KOLs, FDA mandated surgeon training (the instruction of intraoperative implantation techniques, and post-operative care). All were key facets of successfully introducing Xen to ophthalmic surgeons with a goal of achieving optimal patient outcomes. The Xen microsurgical procedure is performed in Hospital Outpatient Surgery Departments and Ambulatory Surgery Centers. Key Accomplishments:• Trained 22 surgeons within nine months of launch. This was the fastest adoption of surgeons completing the most cases compared to any territory in the US.• Sales Representative of the Year in 2017 (42 total representatives competing).• Earned titles “President’s Club Winner” and “Incentive Trip Winner” in 2017. • Achieved quota of well over 115% to plan in 2017; 102% to quota, YTD, August 2019.

Minneapolis, Minnesota, Us

Initiated a consultative sales strategy to grow and retain total sales dollars while converting the process of purchasing ophthalmic surgical products in healthcare facilities (primarily Hospital Outpatient Surgery Departments and Ambulatory Surgery Centers) in Oklahoma from a Direct Purchasing Model to a Distributor Purchasing Model. Key Accomplishments:• Negotiated the conversion of every healthcare facility in Oklahoma from a direct purchasing model to a distributor purchasing model with Precision Lens that didn’t have a current usage contract directly with one of the implant manufacturers we represented (equipment lease agreement, product usage agreement, etc.). • During the time of conversion, grew new business by $650,000. • Successful launches of a new category of intraocular lens and an injectable used during cataract surgery, earning double digit growth month after month for both products. • Provided accurate forecasts and exceeded all quotas and metrics assigned by the CEO and the COO/VP Sales.

Aliso Viejo, Ca, Us

Having strategic launch experience with many implants allowed for the implementation of one of the most innovative launches of a new implant/procedure in the Ophthalmic Marketplace. The design of the Istent Trabecular Micro-Bypass Stent is the smallest implant approved by the FDA for placement into humans. The Istent procedure is termed MIGS (Minimally Invasive Glaucoma Surgery), and this implant is probably the greatest innovation for the treatment of Glaucoma in history. This procedure is indicated to be performed with cataract surgery in Hospital Surgery Departments and Ambulatory Surgery Centers by Glaucoma Surgeons, Cataract Surgeons, and Comprehensive Surgical Ophthalmologists.Key Accomplishments:• Acquired surgeon trials and surgeon adoption that translated into consistent growth from $33,000 during the first 4 months of launch up to $1,500,000 per year.• Produced and sustained surgeons’ product usage to substantially grow top-line sales each quarter to meet all Corporate metrics assigned.• Mastered the non-FDA-approved products to act as the product consultant during Phase 3 FDA clinical trial cases by KOLs of the Istent Inject and Istent Supra (two products in Phase 3 Clinical Trials). The goal was to ensure proper implant insertion and validate that protocol was adhered to in each clinical study case performed at study sites within the territory.

Abbott Park, Illinois, Us

Built customer trust and loyalty through proficient expertise of a full range of ophthalmic products (Intraocular lens Implants (IOLs), insertion systems, phacoemulsification equipment, all equipment accessories, ophthalmic visco devices (OVDs), and micro instrumentation). Targeted Cataract Surgeons, Comprehensive Ophthalmic Surgeons, Glaucoma Surgeons, and Anterior Segment Surgeons in the operating rooms of Ambulatory Surgery Centers and Hospital Outpatient Surgery Departments.Served as field sales trainer and product presenter at educational surgeon events, National Sales Meetings, and other training events. Key Accomplishments:• Grew territory from producing less than $1M in annual sales to generating $4.5M in annual sales in 13 years. One of the top three gross sales producing territories in the United States. • Strategically and successfully launched 13 products & product extensions.National Awards and Acievements • Consistently exceeded assigned quotas (2002, 2003, 2004, 2005, 2008, 2010, 2011, 2012). • President’s Club Winner: 2002 (123% to plan), 2003 (108% to plan), 2008 (113% to plan), 2011 (108% to plan), 2012 (106% to plan).• Masters’ Club Winner: 2002 (123% to plan), 2003 (108% to plan), 2008 (113% to plan), 2011 (108% to plan), 2012 (106% to plan).• Grand Slam (Over 100% in 4 of 5 product categories (2002) • Incentive trips (dependant upon Company's performance plus individual performance): 2003, 2011. • Territory Manager of the Year, Microkeratome Capital Equipment (2002).• Territory Manager of the Year, Phacoemelsification Capital Equipment (2010).• Territory Manager of the Year, Runner-up (2002, 2011)